NIAMS SBIR — Small Business Innovation Research
Supports small businesses and researchers advancing arthritis, skin, and musculoskeletal innovation through staged aid.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) SBIR program (R43/R44) funds U.S. small businesses developing innovative research with commercialization potential in NIAMS's three core disease domains: arthritis and rheumatic diseases, musculoskeletal and bone disorders, and skin conditions. NIAMS administers the program within the NIH-wide SBIR framework, and app…
Small business innovation research with commercialization potential in arthritis, rheumatic diseases, musculoskeletal disorders, bone and muscle biology, and skin diseases.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline